Nightingale Health

Building sustainable healthcare

Health Check

The most advanced health check for the health industry.

Remote Health Check

The most advanced remote health check for the health industry.

How to utilize our products

For healthcare providers

For insurance

For governments and health systems

For consumer health

For telehealth

For medical research

Multi biomarker panel

Technology

Innovation that doesn’t disrupt anything but changes everything.

Megaphone

Mission

Building sustainable healthcare and reducing health inequalities.

Lab machine samples

For research

The gold standard ’omics for the research community.

Read more about our research solutions

Latest news

Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US

Mar 21, 2025

Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025

Mar 18, 2025

The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus

Mar 17, 2025

Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US

Mar 17, 2025

Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki

Mar 12, 2025

Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States

Mar 06, 2025

Subscribe to our newsletter!